Skip to main content
Fig. 5 | Cancer Nanotechnology

Fig. 5

From: Engineering M1-derived nanovesicles loading with docosahexaenoic acid synergizes ferroptosis and immune activation for treating hepatocellular carcinoma

Fig. 5

In vivo fluorescence of DiR-stained RNV@DHA and MNV@DHA on a murine orthotopic H22-Luc tumor-bearing mice. A Real-time fluorescence images of H22-Luc tumor-bearing mice with 100 μL of different intravenous administrations (DHA: 30 mg/kg). B Representative ex vivo fluorescence images of tumors and other tissues of mice upon above treatments. The red circles highlight the regions of tumors

Back to article page